Results 191 to 200 of about 4,515 (264)
Triple procedure for management of traumatic aphakia, glaucoma and mydriasis. [PDF]
Chen B, Li YT, Lu YF.
europepmc +1 more source
Symptomatic treatment of infantile nystagmus: a systematic review. [PDF]
Li X, Huurneman B, Goossens J.
europepmc +1 more source
Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma. [PDF]
Zeppieri M +8 more
europepmc +1 more source
Avoiding Glaucoma Surgery Through Allergen Identification by Skin Testing: A Case Report. [PDF]
Suzuki T +4 more
europepmc +1 more source
Urrets-Zavalia syndrome in angular recession.
de Los Mártires PG.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Expert Opinion on Pharmacotherapy, 2008
Primary open-angle glaucoma is a multifactorial optic neuropathy characterized by the progressive loss of retinal ganglion cells and their axons. However, the primary risk factor is elevated intraocular pressure (IOP), which can damage the optic nerve head (ONH) and until now was the only treatable risk factor.
openaire +3 more sources
Primary open-angle glaucoma is a multifactorial optic neuropathy characterized by the progressive loss of retinal ganglion cells and their axons. However, the primary risk factor is elevated intraocular pressure (IOP), which can damage the optic nerve head (ONH) and until now was the only treatable risk factor.
openaire +3 more sources
Topical brinzolamide-induced ciliary body effusion with secondary angle closure and myopic shift
BMJ Case ReportsHere, we describe a rare case of drug-induced unilateral ciliary body effusion precipitated by topical brinzolamide, presenting acutely with pain, angle closure and myopic shift.
Chelsea Guymer, A. Galanopoulos
semanticscholar +1 more source
Oriental Journal of Chemistry
In the present work, a RP-HPLC technique was used to separate the two drug moieties in simple run with the use of a Hypersil BDS C18 (100 mm x 4.6 mm; 5µ) P/N: 28105-104630 column and isocratic mobile phase with acetonitrile and 65:35 (v/v) 0.02M Octane ...
H. K. Kohli +3 more
semanticscholar +1 more source
In the present work, a RP-HPLC technique was used to separate the two drug moieties in simple run with the use of a Hypersil BDS C18 (100 mm x 4.6 mm; 5µ) P/N: 28105-104630 column and isocratic mobile phase with acetonitrile and 65:35 (v/v) 0.02M Octane ...
H. K. Kohli +3 more
semanticscholar +1 more source

